Phage therapy in the UK
Moving Towards Clinical Trials
This event is part of a broader programme of work on protecting last-line antibiotics through human Phage Therapy (PT) as a complement to antibiotics and other new therapies.
📅 Time and Date
April 22, 2pm to 6pm BST
Thank you for attending our event
The event videos will be posted in the next few weeks. Please check back or look out for the review issue in Capsid & Tail
Thank for attending our event? Did you enjoy the event? Please leave a message or comment for us!
Our mission is to reach a consensus on the pathway to phage therapy in UK and find collaborators in our endeavour, starting with testing phage therapy for bacterial UTIs resistant to antibiotics.
Objectives of the forum
- Create a dialogue between developers of bacteriophages as potential suppliers of phage; Public Health professionals as strategic lead on AMR strategy; Clinicians as potential users as well as representatives of patient groups; Regulators and developers of treatment guidelines as safety guarantor.
- Provide a platform for exploring the promotion of clinical trials of phage therapy in England, including the following aspects:
- Potential modes of application.
- How useful and acceptable these would be for treatment (for patients and clinicians) of antibiotic resistant infections, and therefore for contributing to reduce antimicrobial resistance.
- How would these be regulated, and guidelines developed.
- Develop next steps for acceptability and regulatory aspects
- Learn from clinical trials of phage therapy in other countries
- Create a network for the development of clinical trial of phage therapy in England
- Identify next steps for promotion and development of clinical trials of phage therapy for resistant UTIs in England
- Commitment to continue exploring the feasibility of phage therapy.
- Creation of a network to allow building alliances.
- Understanding who needs to be influenced (e.g. regulators, NHS guidelines, other clinicians, other patient groups).